VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Saturday, January 10, 2026

Wide Moat Stocks Expansion-Stage Stocks Home My Collections

Stock Comparison

Boston Scientific Corporation vs Teqnion AB (publ)

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Boston Scientific Corporation

BSX · New York Stock Exchange

Market cap (USD)$144.7B

Gross margin (TTM)65.1%

Operating margin (TTM)17.3%

Net margin (TTM)14.4%

SectorHealthcare

IndustryMedical - Devices

CountryUS

Data as of2026-01-04

Moat score

65/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.

View BSX analysis

Teqnion AB (publ)

TEQ · Nasdaq First North Growth Market Sweden

Market cap (USD)$3.1B

Gross margin (TTM)—

Operating margin (TTM)—

Net margin (TTM)—

SectorFinancials

IndustryIndustrial - Distribution

CountrySE

Data as of2026-01-08

Moat score

47/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Teqnion AB (publ)'s moat claims, evidence, and risks.

View TEQ analysis

Comparison highlights

Moat score gap: Boston Scientific Corporation leads (65 / 100 vs 47 / 100 for Teqnion AB (publ)).
Segment focus: Boston Scientific Corporation has 5 segments (49.8% in Cardiology); Teqnion AB (publ) has 4 segments.
Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs n/a.
Moat breadth: Boston Scientific Corporation has 6 moat types across 3 domains; Teqnion AB (publ) has 8 across 2.

Primary market context

Boston Scientific Corporation

Cardiology

Market

Cardiology devices (interventional cardiology, structural heart, electrophysiology, cardiac rhythm management and remote monitoring)

Geography

Global

Customer

Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists)

Role

Medical device OEM / implantables + procedure devices + service-enabled monitoring

Revenue share

49.8%

Teqnion AB (publ)

Acquisition & Portfolio Platform (Active, long-term ownership)

Market

Acquisition and long-term ownership of profitable niche industrial SMEs

Geography

Nordics, UK, Ireland

Customer

Business owners / sellers; subsidiary management teams

Role

Acquirer / holding company / active owner

Side-by-side metrics

Boston Scientific Corporation

Teqnion AB (publ)

Ticker / Exchange

BSX - New York Stock Exchange

TEQ - Nasdaq First North Growth Market Sweden

Market cap (USD)

$144.7B

$3.1B

Gross margin (TTM)

65.1%

n/a

Operating margin (TTM)

17.3%

n/a

Net margin (TTM)

14.4%

n/a

Sector

Healthcare

Financials

Industry

Medical - Devices

Industrial - Distribution

HQ country

Primary segment

Cardiology

Acquisition & Portfolio Platform (Active, long-term ownership)

Market structure

Oligopoly

Competitive

Market share

n/a

HHI estimate

n/a

Pricing power

Moderate

n/a

Moat score

65 / 100

47 / 100

Moat domains

Demand, Legal, Supply

Supply, Demand

Last update

2026-01-04

2026-01-08

Moat coverage

Shared moat types

Procurement InertiaDistribution Control

Boston Scientific Corporation strengths

Installed Base ConsumablesTraining Org Change CostsRegulated Standards PipeReputation Reviews

Teqnion AB (publ) strengths

Operational ExcellencePreferential Input AccessScope EconomiesDesign In QualificationSwitching Costs GeneralLearning Curve Yield

Segment mix

Boston Scientific Corporation segments

Full profile >

Endoscopy

Oligopoly

16%

Urology

Competitive

13.1%

Neuromodulation

Oligopoly

6.6%

Cardiology

Oligopoly

49.8%

Peripheral Interventions

Competitive

14.4%

Teqnion AB (publ) segments

Full profile >

Acquisition & Portfolio Platform (Active, long-term ownership)

Competitive

n/a

Agency & Distribution Businesses

Competitive

n/a

Niche Product & Service Companies

Competitive

n/a

Manufacturing (Own-brand and Contract/OEM)

Competitive

n/a

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.